ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,401 | 63.15097 | 1 |
male
| 1 | 41 | 41 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 10 |
$11-$25k
| 0 | 276,936 | 104,526 | 112,121.75 | 28.75 |
white
| 19.398438 | 28 | 0.855957 | 0.761963 | 3 | 0 | 0 |
no
| 0.5 | 0.25 |
dnr after sadm
| 40 | 98 | 11.699219 | 50 | 20 | 35.5 | null | null | 0.899902 | 1.299805 | 149 | null | 429 | 37 | 2,085 | 5 | 1 |
<2 mo. follow-up
| 1 |
1,402 | 58.68597 | 1 |
female
| 0 | 6 | 389 |
Lung Cancer
|
Cancer
| 1 | 12 |
$11-$25k
| 0 | 18,292 | 8,339.8516 | 8,959.875 | 20 |
black
| 16.296875 | 10 | 0.735962 | 0.467957 | 1 | 0 | 0 |
metastatic
| 1 | 1 |
no dnr
| 6 | 57 | 44 | 125 | 35 | 36 | 233.3125 | null | null | 1 | 136 | 7.449219 | 415 | 34 | 1,870 | null | 0 |
no(M2 and SIP pres)
| 0 |
1,403 | 65.19598 | 1 |
male
| 1 | 16 | 16 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 18 |
>$50k
| 44 | null | 67,778.25 | 71,593.0625 | 34.666657 |
white
| 35.5 | 80 | 0.263977 | 0.15799 | 8 | 0 | 0 |
no
| 0.5 | 0.33 |
dnr after sadm
| 11 | 122 | 30.398438 | 125 | 12 | 36.59375 | 300 | null | null | 4 | 145 | 7.419922 | 95 | 119 | 694 | null | 1 |
<2 mo. follow-up
| 1 |
1,404 | 62.81998 | 1 |
male
| 0 | 19 | 300 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 12 |
$11-$25k
| 0 | 62,304 | 31,476.3438 | 29,786.5938 | 18.666656 |
white
| 25.597656 | 23 | 0.799927 | 0.677979 | 1 | 1 | 0 |
no
| 0.8 | 0.6 |
no dnr
| 19 | 67 | 25.398438 | 75 | 10 | 36.09375 | 375 | 4 | 7.799805 | 2.299805 | 133 | 7.349609 | 89 | 46 | 2,785 | null | 0 | null | 0 |
1,405 | 90.35699 | 0 |
male
| 0 | 6 | 542 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 5 |
$11-$25k
| 0 | 9,994 | 6,418.4141 | 4,934.63672 | 13 |
white
| 21.097656 | 30 | 0.751953 | 0.608887 | 1 | 0 | 0 |
no
| 0.9 | 0.75 |
no dnr
| 6 | 66 | 10.5 | 38 | 24 | 35.29688 | null | 3.799805 | 1.799805 | 2 | 139 | null | 105 | 29 | 2,225 | 0 | null | null | 0.494751 |
1,406 | 58.98199 | 0 |
male
| 0 | 8 | 541 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
$25-$50k
| 26 | 267,221 | 23,775.1719 | 22,595.0781 | 28.5 |
asian
| 25.097656 | 26 | 0.644897 | 0.544922 | 31 | 0 | 0 |
no
| 0.9 | 0.8 |
no dnr
| 8 | 57 | 7.799805 | 105 | 12 | 36.59375 | 163.5 | 2.399902 | 36.398438 | 5.199219 | 135 | 7.109375 | 98 | 48 | 240 | 0 | 1 |
no(M2 and SIP pres)
| 1 |
1,407 | 79.896 | 1 |
male
| 1 | 10 | 10 |
Coma
|
Coma
| 3 | null | null | 44 | 73,135 | 28,528.1875 | 32,434.875 | 29.5 |
white
| 25.5 | 63 | 0.297974 | 0.22699 | 1 | 0 | 1 |
no
| 0.1 | 0.05 |
dnr after sadm
| 1 | 127 | 18.699219 | 120 | 38 | 38.59375 | 208.15625 | null | null | 1.699951 | 130 | 7.489258 | null | 19 | 3,186 | null | null |
<2 mo. follow-up
| 5.791992 |
1,408 | 77.74396 | 1 |
female
| 1 | 12 | 12 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 18 |
under $11k
| 0 | 34,096 | 16,873.2656 | 15,810.1797 | 16 |
white
| 16.5 | 20 | 0.861938 | 0.770996 | 1 | 1 | 0 |
no
| 0.95 | 0.8 |
no dnr
| 12 | 57 | 5.899414 | 135 | 22 | 36.89844 | null | 3.599609 | 0.799927 | 1.199951 | 134 | null | null | 25 | 3,120 | 5 | 5 |
<2 mo. follow-up
| 5 |
1,409 | 72.05194 | 1 |
male
| 0 | 9 | 340 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 12 |
under $11k
| 0 | 27,158 | 13,123.1953 | 12,970 | 26.5 |
hispanic
| 17.199219 | 26 | 0.870972 | 0.784912 | 1 | 1 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 9 | 57 | 7.099609 | 65 | 28 | 36.5 | null | null | 0.299988 | 1.199951 | 132 | null | null | 13 | 2,810 | null | null |
no(M2 and SIP pres)
| 3.253418 |
1,410 | 61.49799 | 1 |
female
| 0 | 4 | 196 |
Lung Cancer
|
Cancer
| 2 | 12 | null | 0 | 6,507 | 2,927.2148 | 4,986.19922 | 6 |
white
| 14.298828 | 15 | 0.765991 | 0.515991 | 1 | 1 | 0 |
metastatic
| 0.4 | 0.05 |
no dnr
| 4 | 97 | null | 110 | 22 | 37.89844 | null | null | null | null | 140 | null | 136 | null | 3,100 | 0 | 0 | null | 0 |
1,411 | 53.26797 | 1 |
female
| 1 | 21 | 21 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 16 |
$11-$25k
| 0 | 309,174 | 109,134.188 | 104,876.375 | 38 |
white
| 28.898438 | 39 | 0.7229 | 0.637939 | 7 | 0 | 0 |
no
| null | null |
no dnr
| 21 | 55 | 27.597656 | 95 | 10 | 38.69531 | 267.5 | null | 13 | 3.699707 | 132 | 7.55957 | null | 61 | 0 | 0 | null |
<2 mo. follow-up
| 0.494751 |
1,412 | 67.16998 | 1 |
male
| 1 | 26 | 26 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | null | null | 0 | 326,479 | 129,416.938 | 132,201.875 | 44.25 |
white
| 30.5 | 65 | 0.662964 | 0.565918 | 2 | 0 | 0 |
no
| 0.5 | 0.5 |
dnr after sadm
| 22 | 73 | 14.199219 | 55 | 24 | 36.5 | null | 2.599609 | 0.699951 | 1.599854 | 135 | null | 165 | 37 | 4,220 | null | null |
<2 mo. follow-up
| 2.918945 |
1,413 | 86.41998 | 1 |
male
| 1 | 16 | 16 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
$11-$25k
| 9 | 88,769 | 34,941.5625 | 32,367.75 | 21.666656 |
white
| 42.796875 | 63 | 0.182983 | 0.094986 | 1 | 0 | 0 |
no
| 0.5 | 0.5 |
dnr after sadm
| 2 | 65 | 11.898438 | 124 | 52 | 39.39844 | null | null | null | 0.799927 | 136 | null | 116 | 22 | 1,425 | null | null |
<2 mo. follow-up
| 4.041992 |
1,414 | 48.76898 | 0 |
male
| 0 | 27 | 534 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 14 |
>$50k
| 44 | 318,152 | 72,123.125 | 67,590.3125 | 31.25 |
white
| 23.796875 | 43 | 0.709961 | 0.621948 | 4 | 0 | 0 |
no
| 0.9 | 0.8 |
no dnr
| 27 | 70 | null | 55 | 20 | 36 | null | null | null | 2 | 139 | null | 117 | 40 | 1,745 | null | 0 |
no(M2 and SIP pres)
| 0 |
1,415 | 41.12799 | 1 |
female
| 0 | 27 | 103 |
Coma
|
Coma
| 2 | 14 |
$25-$50k
| 44 | 141,917 | 56,199.0625 | 55,028.6875 | 27.75 |
white
| 31.5 | 45 | 0.516968 | 0.445984 | 1 | 0 | 0 |
no
| null | null |
dnr after sadm
| 22 | 107 | 1.899902 | 60 | 26 | 38 | 336.625 | 2.699707 | 0.699951 | 1.599854 | 133 | 7.459961 | 98 | 16 | 2,313 | null | 7 | null | 7 |
1,416 | 52.31998 | 0 |
male
| 0 | 4 | 531 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 16 |
>$50k
| 0 | 14,200 | 8,216.9844 | 8,403.46875 | 17 |
white
| 13.398438 | 18 | 0.935913 | 0.891968 | 1 | 1 | 0 |
no
| 0.9 | 0.8 |
no dnr
| 4 | 63 | 7 | 75 | 40 | 38 | 67.76562 | 1.899902 | 0.599976 | 1.099854 | 132 | 7.519531 | 113 | 26 | 1,496 | null | null |
no(M2 and SIP pres)
| 2.151367 |
1,417 | 71.75397 | 0 |
male
| 0 | 38 | 531 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 18 | null | 26 | 198,019 | 80,928.8125 | 77,727.6875 | 28.75 |
white
| 28.296875 | 35 | 0.532959 | 0.417969 | 6 | 1 | 0 |
no
| 0.85 | 0.85 |
no dnr
| 38 | 71 | 8.099609 | 66 | 22 | 35.59375 | null | null | 0.799927 | 1 | 140 | null | 413 | 18 | 2,975 | null | 5 | null | 5 |
1,418 | 64.41595 | 1 |
female
| 1 | 13 | 13 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5 | 10 |
$11-$25k
| 44 | 81,959 | 30,076.3281 | 30,402.0938 | 31 |
hispanic
| 19 | 24 | 0.737915 | 0.656982 | 3 | 0 | 0 |
no
| null | null |
dnr after sadm
| 10 | 65 | 10.798828 | 70 | 32 | 36.39844 | 376.1875 | null | null | 1.199951 | 140 | 7.399414 | 156 | 24 | 1,925 | null | 7 |
<2 mo. follow-up
| 7 |
1,419 | 56.66299 | 0 |
female
| 0 | 17 | 529 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null | null | 37 | 184,814 | 42,421.6875 | 40,814.5312 | 22 |
white
| 24.796875 | 19 | 0.650879 | 0.550903 | 8 | 0 | 0 |
no
| null | null |
no dnr
| 17 | 66 | 12.398438 | 64 | 22 | 36.39844 | null | 3.799805 | null | 0.799927 | 136 | null | 260 | 14 | 2,350 | null | null | null | 2.577637 |
1,420 | 20.73099 | 0 |
male
| 0 | 21 | 528 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 12 |
under $11k
| 61 | null | 59,732.75 | 58,575.2812 | 28.333328 |
hispanic
| 29.597656 | 37 | 0.62793 | 0.524902 | 12 | 0 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 21 | 48 | 15.798828 | 100 | 24 | 38 | 273.3125 | null | null | 1.5 | 130 | 7.539062 | null | 24 | 1,745 | null | null |
no(M2 and SIP pres)
| 2.806641 |
1,421 | 77.31097 | 0 |
male
| 0 | 56 | 528 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null |
under $11k
| 9 | 318,057 | 94,745.25 | 94,802.1875 | 26.25 |
black
| 26.597656 | 32 | 0.504883 | 0.387939 | 19 | 0 | 0 |
yes
| 0.85 | 0.8 |
no dnr
| 56 | 50 | 9.5 | 135 | 13 | 39.39844 | 196 | 1.599854 | 1.799805 | 0.899902 | 135 | 7.369141 | 236 | 21 | 1,800 | null | 0 |
no(M2 and SIP pres)
| 0 |
1,422 | 56.03299 | 1 |
male
| 1 | 6 | 6 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 18 |
$11-$25k
| 100 | 52,414 | 21,598.75 | 21,937.3594 | 34 |
white
| 40.398438 | 77 | 0.044998 | 0.014 | 2 | 0 | 0 |
no
| null | null |
dnr after sadm
| 3 | 78 | 12 | 115 | 36 | 36.79688 | 71.65625 | null | null | 3.899902 | 128 | 7.489258 | 145 | 73 | 2,350 | null | 0 |
<2 mo. follow-up
| 0 |
1,423 | 76.42999 | 1 |
male
| 0 | 11 | 62 |
Lung Cancer
|
Cancer
| 1 | 12 |
>$50k
| 0 | 29,862 | 14,500.4219 | 17,274.4688 | 15.5 |
white
| 16.296875 | 13 | 0.694946 | 0.405945 | 1 | 0 | 0 |
metastatic
| 0.95 | 0.5 |
no dnr
| 11 | 70 | 14.699219 | 75 | 10 | 38.19531 | 212 | null | 1.599854 | 3.099609 | 152 | 7.519531 | 492 | 111 | 2,264 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
1,424 | 69.58795 | 1 |
male
| 0 | 5 | 240 |
Lung Cancer
|
Cancer
| 1 | 16 | null | 0 | 9,532 | 4,846.543 | 4,340.04688 | 10 |
other
| 16.699219 | 6 | 0.703979 | 0.418945 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.6 |
no dnr
| 5 | 65 | 17.597656 | 165 | 26 | 38.39844 | 85 | null | null | 1 | 132 | 7.359375 | 253 | 18 | 1,440 | null | null | null | 2.340332 |
1,425 | 70.32996 | 1 |
female
| 0 | 15 | 28 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 12 |
$25-$50k
| 37 | 65,043 | 28,584.9375 | 26,608.6719 | 21 |
white
| 24.199219 | 46 | 0.514893 | 0.397949 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 15 | 62 | 9.699219 | 65 | 20 | 36.19531 | null | 3.899902 | 0.599976 | 0.899902 | 139 | null | 124 | 18 | 1,660 | null | 1 |
<2 mo. follow-up
| 1 |
1,426 | 68.34497 | 1 |
female
| 0 | 16 | 236 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 16 |
>$50k
| 26 | 118,074 | 28,804.5938 | 27,936.1875 | 18.333328 |
white
| 22.5 | 32 | 0.660889 | 0.562988 | 20 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 16 | 85 | 20.296875 | 125 | 30 | 38.59375 | 315.5 | null | null | 2.899902 | 147 | 7.429688 | 101 | 68 | 2,545 | null | null | null | 2.81543 |
1,427 | 76.76099 | 1 |
male
| 0 | 24 | 28 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 16 |
$25-$50k
| 0 | 82,924 | 40,077.5312 | 37,836.375 | 24.333328 |
white
| 27.898438 | 34 | 0.692993 | 0.526978 | 1 | 0 | 0 |
no
| 0.78 | 0.68 |
no dnr
| 24 | 73 | 5.899414 | 75 | 10 | 38.29688 | 186 | null | null | 1.399902 | 152 | 7.339844 | null | 38 | 548 | 2 | 2 |
<2 mo. follow-up
| 2 |
1,428 | 58.823 | 1 |
female
| 0 | 12 | 440 |
CHF
|
COPD/CHF/Cirrhosis
| 1 | 14 |
$11-$25k
| 0 | 58,144 | 31,806.9531 | 33,860.8125 | 16.5 |
white
| 32.796875 | 31 | 0.691895 | 0.525879 | 1 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 12 | 98 | 19.5 | 115 | 29 | 38.69531 | 585 | null | 0.699951 | 0.599976 | 131 | 7.519531 | 172 | 12 | 3,055 | null | null | null | 3.062988 |
1,429 | 31.79999 | 1 |
female
| 1 | 24 | 24 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5 | 12 |
under $11k
| 26 | 285,267 | 71,898.625 | 81,949.5 | 40 |
black
| 22.597656 | 57 | 0.819946 | 0.759888 | 12 | 1 | 0 |
no
| 0.7 | 0.6 |
dnr after sadm
| 21 | 115 | 14.699219 | 140 | 24 | 39.29688 | 402.5 | null | 5.299805 | 1.099854 | 128 | 7.459961 | 221 | 18 | 3,765 | null | 2 |
<2 mo. follow-up
| 2 |
1,430 | 55.32898 | 1 |
male
| 0 | 11 | 38 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 14 |
>$50k
| 0 | 39,435 | 17,091.9219 | 19,060.6094 | 25.5 |
white
| 22.398438 | 27 | 0.863892 | 0.774902 | 1 | 0 | 0 |
no
| 0.85 | 0.7 |
no dnr
| 11 | 82 | 20.199219 | 110 | 26 | 37.39844 | 137.5 | 2.299805 | null | 1.399902 | 140 | 7.429688 | 104 | 12 | 1,148 | 0 | 0 |
<2 mo. follow-up
| 0 |
1,431 | 55.35098 | 0 |
male
| 0 | 24 | 517 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null | null | 100 | 559,190 | 115,602.375 | 110,042.312 | 38.333313 |
white
| 36.5 | 74 | 0.054993 | 0.017998 | 21 | 0 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 24 | 65 | 12.099609 | 115 | 31 | 37.79688 | 220 | 2.699707 | 46.5 | 7.799805 | 138 | 7.5 | 184 | 96 | 328 | null | null | null | 3.620117 |
1,432 | 40.05197 | 1 |
female
| 0 | 11 | 515 |
Colon Cancer
|
Cancer
| 1 | 14 | null | 0 | 26,709 | 12,503.6719 | 12,794.4844 | 15 |
asian
| 14.599609 | 15 | 0.881958 | 0.73291 | 1 | 0 | 0 |
metastatic
| 0.4 | 0.2 |
no dnr
| 11 | 77 | 13.699219 | 80 | 20 | 36.59375 | null | null | null | 1.199951 | 134 | null | null | 14 | 2,900 | 0 | null |
no(M2 and SIP pres)
| 0.494751 |
1,433 | 33.043 | 0 |
male
| 0 | 62 | 515 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 11 |
$11-$25k
| 37 | 584,811 | 161,002.25 | 140,531.625 | 34.75 |
hispanic
| 31.296875 | 51 | 0.640991 | 0.539917 | 6 | 0 | 0 |
no
| 0.5 | 0.5 |
no dnr
| 62 | 83 | 3 | 104 | 22 | 39.19531 | null | null | 0.799927 | 1.299805 | 138 | null | 144 | 15 | 2,750 | null | null |
no(M2 and SIP pres)
| 3.351074 |
1,434 | 75.20898 | 1 |
female
| 0 | 7 | 212 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 14 | null | 0 | 16,236 | 8,621.3047 | 6,855.44922 | 15.5 |
hispanic
| 21.796875 | 32 | 0.805908 | 0.68689 | 1 | 0 | 0 |
no
| 0.9 | 0.7 |
no dnr
| 7 | 67 | 20.597656 | 55 | 25 | 36 | 371 | null | 0.299988 | 1.199951 | 129 | 7.609375 | 289 | 25 | 1,466 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
1,435 | 59.55099 | 1 |
male
| 1 | 8 | 8 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 0 | 49,137 | 22,125.8438 | 22,604.9062 | 13.5 |
white
| 18.199219 | 17 | 0.809937 | 0.746948 | 2 | 0 | 0 |
metastatic
| 0.2 | 0.04 |
dnr after sadm
| 1 | 68 | 13.699219 | 145 | 32 | 37.69531 | 344 | null | null | 0.799927 | 140 | 7.539062 | 133 | 14 | 2,183 | null | null |
<2 mo. follow-up
| 3.342285 |
1,436 | 65.30298 | 1 |
male
| 1 | 7 | 7 |
Coma
|
Coma
| 1 | 16 | null | 55 | 114,803 | 25,911.7031 | 28,150.0156 | 36.5 |
white
| 28.296875 | 51 | 0.200989 | 0.139984 | 13 | 1 | 0 |
no
| 0.1 | 0.1 |
dnr after sadm
| 7 | 46 | 8.099609 | 75 | 22 | 36.5 | null | 3.399902 | 2.099609 | 1.299805 | 130 | null | 108 | 35 | 3,113 | null | 1 |
<2 mo. follow-up
| 1 |
1,437 | 34.31299 | 1 |
male
| 1 | 7 | 7 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 14 |
under $11k
| 37 | 109,897 | 21,670.1406 | 22,389.4375 | 18 |
white
| 44.195313 | 74 | 0.237 | 0.135986 | 17 | 0 | 0 |
no
| 0.2 | 0.05 |
dnr after sadm
| 1 | 49 | 5 | 55 | 22 | 35.79688 | null | null | null | 0.699951 | 124 | null | null | 25 | 3,550 | null | 1 |
<2 mo. follow-up
| 1 |
1,438 | 68.51495 | 1 |
female
| 0 | 28 | 163 |
Coma
|
Coma
| 0 | 16 | null | 61 | 269,996 | 97,231.25 | 87,709.5 | 39 |
white
| 25 | 25 | 0.276978 | 0.207977 | 4 | 0 | 0 |
no
| 0.75 | 0.75 |
no dnr
| 28 | 60 | 25.597656 | 65 | 34 | 38.5 | 247.5 | null | 0.199982 | 5.599609 | 136 | 7.469727 | null | 79 | 0 | null | 0 |
Coma or Intub
| 0 |
1,439 | 70.56494 | 1 |
female
| 0 | 6 | 137 |
Lung Cancer
|
Cancer
| 1 | 20 | null | 0 | 13,976 | 7,062.5586 | 5,859.62891 | 19 |
white
| 16 | 32 | 0.714966 | 0.434998 | 1 | 0 | 0 |
metastatic
| 0.95 | 0.7 |
no dnr
| 6 | 63 | 10.398438 | 75 | 16 | 36.29688 | null | 3.699707 | 2.399902 | 1.5 | 126 | null | 94 | 24 | 3,625 | null | null |
no(M2 and SIP pres)
| 2.323242 |
1,440 | 59.31 | 1 |
female
| 0 | 16 | 131 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 4 | null | null | 9 | 45,458 | 22,102.3906 | 21,661.0781 | 16.333328 |
white
| 25.097656 | 26 | 0.672974 | 0.500977 | 1 | 0 | 0 |
no
| 0.5 | 0.4 |
no dnr
| 16 | 132 | 2.399902 | 125 | 44 | 37.79688 | 182 | null | 1.199951 | 4.399414 | 140 | 7.339844 | 356 | 91 | 492 | null | null | null | 4.161133 |
1,441 | 35.17297 | 1 |
male
| 1 | 5 | 5 |
MOSF w/Malig
|
ARF/MOSF
| 2 | 12 |
$11-$25k
| 61 | 194,955 | 24,154.5312 | 24,888.5312 | 48 |
hispanic
| 21 | 21 | 0.430969 | 0.310974 | 40 | 0 | 0 |
yes
| 0.01 | 0 |
dnr after sadm
| 4 | 106 | 8.699219 | 76 | 14 | 37.5 | null | null | 0.299988 | 0.799927 | 132 | null | 85 | 11 | 1,800 | null | 0 |
<2 mo. follow-up
| 0 |
1,442 | 60.39999 | 1 |
male
| 0 | 7 | 499 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 10 | null | 0 | 81,201 | 10,525.8984 | 11,691.6562 | 15 |
white
| 18.796875 | 22 | 0.697998 | 0.60791 | 5 | 0 | 0 |
metastatic
| null | null |
no dnr
| 7 | 128 | 31.398438 | 125 | 25 | 39 | 192 | 2.5 | 6.099609 | 0.799927 | 151 | 7.439453 | 99 | 32 | 6,065 | null | 0 |
adl>=4 (>=5 if sur)
| 0 |
1,443 | 37.96298 | 1 |
male
| 1 | 10 | 10 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 13 |
$11-$25k
| 37 | 569,861 | 52,801.5938 | 52,417.7812 | 53 |
white
| 38.59375 | 74 | 0.362 | 0.243988 | 28 | 0 | 0 |
no
| 0.05 | 0.05 |
dnr after sadm
| 10 | 63 | 6.699219 | 105 | 20 | 36 | null | null | null | 1.899902 | 137 | null | null | 42 | 1,875 | null | 0 |
<2 mo. follow-up
| 0 |
1,444 | 56.56097 | 0 |
male
| 0 | 48 | 494 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 16 |
>$50k
| 26 | 690,753 | 141,858.875 | 132,413.375 | 44.25 |
white
| 38.5 | 60 | 0.28595 | 0.176971 | 36 | 0 | 0 |
no
| 0.2 | 0.2 |
no dnr
| 48 | 72 | 9.798828 | 72 | 28 | 36.39844 | null | null | null | 0.699951 | 136 | null | 159 | 7 | 3,625 | null | null | null | 2.624512 |
1,445 | 65.29999 | 0 |
female
| 0 | 4 | 494 |
Lung Cancer
|
Cancer
| 2 | null | null | 0 | 14,436 | 6,510.1836 | 8,984.05469 | 20 |
white
| 15.5 | 14 | 0.736938 | 0.468994 | 1 | 0 | 0 |
metastatic
| null | null |
no dnr
| 4 | 122 | 6.199219 | 145 | 8 | 38.89844 | 476.1875 | null | 2.899902 | 2.399902 | 130 | 7.569336 | null | 54 | 2,518 | null | null | null | 3.448731 |
1,446 | 84.08496 | 0 |
male
| 0 | 12 | 493 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 16 |
>$50k
| 0 | 29,939 | 17,392.6406 | 11,688.7031 | 8.5 |
white
| 19.398438 | 14 | 0.805908 | 0.685913 | 1 | 0 | 0 |
no
| 0.8 | 0.6 |
no dnr
| 12 | 117 | 19.5 | 103 | 24 | 36.19531 | null | null | null | 1.899902 | 134 | null | 175 | 46 | null | null | 0 |
no(M2 and SIP pres)
| 0 |
1,447 | 71.05798 | 1 |
female
| 0 | 33 | 373 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 12 |
$11-$25k
| 26 | 178,983 | 66,084 | 67,346 | 27.25 |
white
| 36.296875 | 58 | 0.250977 | 0.146973 | 3 | 0 | 0 |
yes
| 0.8 | 0.7 |
no dnr
| 33 | 115 | 1.599854 | 35 | 50 | 37.59375 | 72.5 | null | 5.199219 | 0.799927 | 137 | 7.419922 | 192 | 32 | 1,075 | null | 0 |
no(M2 and SIP pres)
| 0 |
1,448 | 36.33099 | 1 |
male
| 1 | 15 | 15 |
Coma
|
Coma
| 0 | null | null | 94 | 191,073 | 76,378.6875 | 77,532.0625 | 55.333313 |
white
| 34.296875 | 81 | 0.202972 | 0.141998 | 2 | 0 | 0 |
no
| 0.1 | 0.1 |
dnr after sadm
| 10 | 120 | 12.798828 | 125 | 30 | 39.19531 | null | null | 0.899902 | 0.699951 | 131 | null | 146 | 14 | 2,795 | null | null |
<2 mo. follow-up
| 2.785645 |
1,449 | 78.26996 | 1 |
female
| 0 | 6 | 263 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null |
under $11k
| 41 | 155,711 | 10,424.0391 | 10,553.8672 | 31 |
white
| 27.199219 | 47 | 0.312988 | 0.199982 | 20 | 1 | 0 |
yes
| 0.5 | 0.4 |
no dnr
| 6 | 73 | 0.199982 | 72 | 24 | 38.19531 | null | null | null | 0.599976 | 132 | null | null | 6 | 2,150 | null | 2 |
Coma or Intub
| 2 |
1,450 | 83.49597 | 0 |
male
| 0 | 21 | 491 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 9 | null | 26 | 174,489 | 53,113.5938 | 54,059.2188 | 30 |
white
| 27.199219 | 34 | 0.407959 | 0.28894 | 5 | 0 | 0 |
yes
| 0.5 | 0.5 |
no dnr
| 21 | 103 | 7.099609 | 67 | 24 | 36.09375 | 220 | null | 0.399963 | 1 | 140 | 7.359375 | 169 | 18 | null | null | null | null | 4.511719 |
1,451 | 48.58298 | 0 |
male
| 0 | 30 | 489 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | null | null | 0 | 222,936 | 110,012.125 | 93,727.6875 | 34 |
white
| 22.898438 | 28 | 0.876953 | 0.795898 | 1 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 30 | 68 | 9.898438 | 98 | 24 | 36.19531 | null | 2.399902 | 7.399414 | 0.599976 | 143 | null | 103 | 3 | 3,800 | null | null | null | 3.19043 |
1,452 | 63.33499 | 1 |
male
| 0 | 10 | 467 |
Colon Cancer
|
Cancer
| 1 | 16 |
>$50k
| 0 | 43,200 | 20,651.7812 | 23,585.8906 | 11.5 |
white
| 16.199219 | 14 | 0.829956 | 0.630981 | 1 | 0 | 0 |
metastatic
| 1 | 0.5 |
no dnr
| 10 | 105 | 9.398438 | 50 | 26 | 39 | 480 | null | null | 0.699951 | 132 | 7.509766 | 271 | 10 | 2,570 | 0 | 1 | null | 1 |
1,453 | 34.53497 | 1 |
female
| 1 | 18 | 18 |
MOSF w/Malig
|
ARF/MOSF
| 3 | null | null | 44 | 437,598 | 107,912.312 | 95,340.5625 | 44 |
hispanic
| 41.5 | 93 | 0.032997 | 0.008999 | 28 | 0 | 0 |
yes
| 0.35 | 0.25 |
dnr after sadm
| 10 | 110 | 4.599609 | 62 | 24 | 36.79688 | null | null | null | 1.299805 | 138 | null | 366 | 33 | 4,400 | null | null |
<2 mo. follow-up
| 4.182617 |
1,454 | 53.69699 | 0 |
male
| 0 | 21 | 488 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 12 |
$25-$50k
| 0 | 155,191 | 91,163.625 | 69,184.875 | 25.666656 |
white
| 16.597656 | 16 | 0.915894 | 0.85791 | 1 | 0 | 0 |
no
| null | null |
no dnr
| 21 | 65 | 8.898438 | 125 | 10 | 38.39844 | 176 | 3.099609 | 32 | 4.799805 | 141 | 7.419922 | 178 | 61 | 12 | 0 | 0 | null | 0 |
1,455 | 46.89099 | 0 |
female
| 0 | 10 | 489 |
CHF
|
COPD/CHF/Cirrhosis
| 6 | null |
$11-$25k
| 37 | 108,058 | 65,461.0312 | 45,364.6875 | 38.5 |
white
| 36.398438 | 56 | 0.526978 | 0.326965 | 1 | 0 | 0 |
no
| 0.95 | 0.93 |
no dnr
| 10 | 108 | 2.099609 | 135 | 26 | 38.29688 | 142 | null | 0.599976 | 5.799805 | 132 | 7.299805 | null | 50 | 1,045 | 1 | 0 | null | 0 |
1,456 | 66.89099 | 0 |
male
| 0 | 22 | 487 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | null | null | 44 | 223,592 | null | null | 29 |
white
| 23.898438 | 38 | 0.570923 | 0.459961 | 12 | 0 | 0 |
no
| 0.8 | 0.75 |
no dnr
| 22 | 107 | 18.097656 | 66 | 24 | 38 | null | null | null | 0.899902 | 136 | null | 170 | 6 | 1,175 | null | null | null | 3.091797 |
1,457 | 31.17599 | 1 |
female
| 1 | 24 | 24 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 4 | 11 |
$11-$25k
| 61 | 558,904 | 144,282.875 | 138,522 | 50.333313 |
hispanic
| 42.59375 | 95 | 0.181 | 0.093994 | 22 | 0 | 0 |
no
| 0.7 | 0.5 |
dnr after sadm
| 14 | 70 | null | 70 | 20 | 36.5 | 521.625 | null | 0.899902 | 1.799805 | 131 | 7.429688 | 157 | 19 | 2,050 | null | 7 |
<2 mo. follow-up
| 7 |
1,458 | 77.55499 | 1 |
female
| 0 | 25 | 33 |
Coma
|
Coma
| 2 | null | null | 44 | 168,806 | 38,366.5625 | 34,710.125 | 24.75 |
white
| 27.5 | 47 | 0.181 | 0.122986 | 7 | 1 | 0 |
no
| 0.4 | 0.3 |
dnr after sadm
| 4 | 43 | 14.898438 | 125 | 10 | 38 | 360 | 1.399902 | 0.599976 | 2.599609 | 133 | 7.319336 | 398 | 36 | 5,960 | null | 3 |
<2 mo. follow-up
| 3 |
1,459 | 36.70099 | 1 |
female
| 1 | 6 | 6 |
Coma
|
Coma
| 3 | 14 |
$11-$25k
| 100 | 139,607 | 32,443.6719 | 34,617.1875 | 50 |
white
| 47.398438 | 97 | 0 | 0 | 11 | 0 | 0 |
yes
| 0.2 | 0.2 |
no dnr
| 6 | 53 | 1.799805 | 125 | 30 | 34.79688 | 445.6875 | null | 0.299988 | 2.399902 | 134 | 7.389648 | 211 | 18 | 34 | null | null |
<2 mo. follow-up
| 3.439453 |
1,460 | 52.24899 | 0 |
male
| 0 | 25 | 480 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null |
$11-$25k
| 26 | 154,101 | 60,022.8125 | 59,715.5 | 26.5 |
white
| 21.898438 | 38 | 0.770996 | 0.696899 | 7 | 0 | 0 |
no
| 0.9 | 0.9 |
no dnr
| 25 | 112 | 10.298828 | 120 | 40 | 35.89844 | 332 | null | null | 1.799805 | 138 | 7.469727 | null | 48 | 3,240 | null | 0 | null | 0 |
1,461 | 80.23499 | 1 |
female
| 1 | 5 | 5 |
MOSF w/Malig
|
ARF/MOSF
| 1 | null | null | 0 | 22,474 | 9,052.9141 | 10,659.0234 | 29 |
other
| 36.5 | 47 | 0.251953 | 0.14798 | 1 | 0 | 0 |
metastatic
| 0.1 | 0 |
no dnr
| 5 | 67 | 0.5 | 120 | 24 | 38.19531 | null | 2.399902 | 1.099854 | 1.199951 | 135 | null | 226 | 33 | 5,400 | null | null |
<2 mo. follow-up
| 3.253418 |
1,462 | 47.49298 | 1 |
male
| 0 | 7 | 404 |
Colon Cancer
|
Cancer
| 2 | 12 |
>$50k
| 0 | 32,899 | 15,341.8359 | 19,223.4062 | 6.5 |
white
| 8.798828 | 7 | 0.917969 | 0.80896 | 1 | 0 | 0 |
metastatic
| 1 | 0.9 |
no dnr
| 7 | 62 | 12.5 | 65 | 29 | 37.89844 | 66.25 | null | null | 1.299805 | 142 | 7.489258 | 126 | 31 | 2,175 | 0 | 0 |
no(M2 and SIP pres)
| 0 |
1,463 | 64.75 | 0 |
male
| 0 | 18 | 477 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 17 |
>$50k
| 0 | 161,773 | 34,648.2188 | 30,380.1719 | 23.333328 |
white
| 26.597656 | 38 | 0.622925 | 0.518921 | 20 | 0 | 0 |
yes
| 0.8 | 0.8 |
no dnr
| 18 | 70 | 9.099609 | 125 | 20 | 36.5 | null | null | null | 1.299805 | 130 | null | null | 26 | 4,940 | null | null | null | 3.260254 |
1,464 | 39.78098 | 0 |
male
| 0 | 13 | 476 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 14 |
>$50k
| 0 | 87,541 | 17,153.9219 | 14,720.9297 | 19.5 |
white
| 27.398438 | 36 | 0.757935 | 0.681885 | 6 | 0 | 0 |
yes
| 0.95 | 0.95 |
no dnr
| 13 | 102 | 11.099609 | 80 | 24 | 36.39844 | null | null | 1.299805 | 1.199951 | 136 | null | 161 | 16 | 1,425 | 0 | null | null | 0.494751 |
1,465 | 79.70398 | 1 |
female
| 0 | 5 | 335 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 14 |
$11-$25k
| 0 | 28,450 | 12,693.6328 | 14,254.0781 | 35 |
white
| 30.199219 | 50 | 0.625 | 0.439941 | 1 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 5 | 65 | 0.049995 | 145 | 12 | 36.19531 | 421.25 | 1.899902 | 5.599609 | 3.199707 | 148 | 7.5 | 374 | 90 | 1,356 | null | 0 |
no(M2 and SIP pres)
| 0 |
1,466 | 64.25696 | 0 |
male
| 0 | 8 | 474 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 14 |
under $11k
| 9 | 52,715 | 16,607.4531 | 15,969.4375 | 17 |
white
| 21.199219 | 28 | 0.802979 | 0.737915 | 3 | 1 | 0 |
no
| 0.9 | 0.75 |
no dnr
| 8 | 62 | 7.399414 | 70 | 14 | 36.19531 | null | null | null | 1.5 | 137 | null | null | 13 | 2,095 | null | 0 |
no(M2 and SIP pres)
| 0 |
1,467 | 48.375 | 1 |
female
| 0 | 10 | 106 |
Lung Cancer
|
Cancer
| 1 | 19 |
>$50k
| 0 | 19,535 | 10,733.4609 | 11,613.3359 | 10 |
white
| 14.099609 | 11 | 0.791992 | 0.56189 | 1 | 0 | 0 |
metastatic
| 0.85 | 0.5 |
no dnr
| 10 | 48 | 15.898438 | 145 | 8 | 38.09375 | 130 | 3.299805 | 1.699951 | 0.799927 | 146 | 7.5 | 198 | 20 | 4,120 | 0 | null | null | 0.494751 |
1,468 | 52.293 | 1 |
male
| 0 | 11 | 440 |
Colon Cancer
|
Cancer
| 1 | 18 |
>$50k
| 0 | 24,621 | 12,094.4141 | 13,190.0625 | 14 |
white
| 11.599609 | 14 | 0.892944 | 0.755981 | 1 | 0 | 0 |
metastatic
| 0.75 | 0.1 |
no dnr
| 11 | 140 | 12.099609 | 65 | 34 | 38.19531 | 159.15625 | 4.599609 | 1.599854 | 0.799927 | 132 | 7.419922 | 180 | 28 | 1,635 | 0 | 0 | null | 0 |
1,469 | 69.91595 | 0 |
male
| 0 | 28 | 472 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | null | null | 37 | 269,095 | 69,369.1875 | 68,555.5625 | 37.5 |
white
| 32.59375 | 73 | 0.265991 | 0.159973 | 8 | 1 | 0 |
yes
| null | null |
no dnr
| 28 | 130 | 12.099609 | 145 | 26 | 39.39844 | 334 | 2.099609 | 34 | 2.599609 | 156 | 7.609375 | 648 | 96 | 1,775 | null | null | null | 3.459961 |
1,470 | 60.20499 | 0 |
female
| 0 | 17 | 472 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | 14 |
>$50k
| 26 | 189,109 | 46,810.6562 | 36,146.2812 | 25 |
asian
| 35.59375 | 64 | 0.265991 | 0.159973 | 25 | 0 | 0 |
yes
| 0.5 | 0.25 |
no dnr
| 17 | 72 | 19.597656 | 115 | 32 | 37.5 | 197.9375 | null | null | 1.699951 | 155 | 7.539062 | 468 | 69 | 2,455 | null | 0 |
no(M2 and SIP pres)
| 0 |
1,471 | 60.91699 | 1 |
female
| 0 | 5 | 254 |
Lung Cancer
|
Cancer
| 1 | 16 |
under $11k
| 0 | 13,116 | 6,205.8125 | 6,476.56641 | 12 |
white
| 14.398438 | 11 | 0.763916 | 0.513916 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.4 |
no dnr
| 5 | 128 | 6.5 | 120 | 36 | 38.59375 | 127.5 | 2.299805 | 36 | 3 | 129 | 7.539062 | null | 69 | 213 | null | null |
no(M2 and SIP pres)
| 2.241699 |
1,472 | 53.75198 | 1 |
male
| 1 | 15 | 15 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 0 | 345,497 | 81,596.1875 | 86,074.3125 | 56 |
white
| 44 | 88 | 0.320984 | 0.20697 | 8 | 0 | 0 |
no
| 0.9 | 0.8 |
no dnr
| 15 | 67 | 22.796875 | 130 | 10 | 37.89844 | 200 | null | 0.799927 | 0.899902 | 138 | 7.479492 | 227 | 16 | 1,245 | null | null |
<2 mo. follow-up
| 2.504395 |
1,473 | 30.53799 | 0 |
male
| 0 | 9 | 468 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | 16 |
$25-$50k
| 26 | 130,205 | 21,199.2188 | 23,719.5156 | 24 |
white
| 19.5 | 20 | 0.851929 | 0.800903 | 28 | 0 | 0 |
no
| 0.8 | 0.8 |
no dnr
| 9 | 82 | 1.5 | 115 | 30 | 37.59375 | 176.1875 | null | null | 1 | 123 | 7.479492 | 173 | 26 | 1,700 | 1 | 1 | null | 1 |
1,474 | 73.84796 | 1 |
female
| 1 | 8 | 8 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5 | 18 |
$11-$25k
| 44 | 77,209 | 27,299.3438 | 28,369.9688 | 34 |
hispanic
| 40.5 | 80 | 0.138977 | 0.064987 | 2 | 1 | 0 |
no
| 0.5 | 0.4 |
dnr after sadm
| 8 | 94 | 6.299805 | 106 | 24 | 36.59375 | null | 4.199219 | 0.5 | 1.099854 | 138 | null | 78 | 16 | 1,900 | null | null |
<2 mo. follow-up
| 4.28418 |
1,475 | 63.93399 | 1 |
female
| 1 | 10 | 10 |
Colon Cancer
|
Cancer
| 1 | 14 | null | 0 | 39,476 | 16,393.5781 | 17,796.2969 | 14.5 |
white
| 40 | 30 | 0.27594 | 0.040993 | 1 | 0 | 0 |
metastatic
| 0.5 | 0 |
dnr after sadm
| 8 | 131 | 6.299805 | 116 | 25 | 38.19531 | 197.125 | null | null | 2.299805 | 147 | 7.459961 | null | null | 5,658 | null | 6 |
<2 mo. follow-up
| 6 |
1,476 | 71.69299 | 1 |
female
| 1 | 10 | 10 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2 | 16 |
$11-$25k
| 61 | 164,001 | 23,916.8125 | 24,213.8281 | 38.5 |
white
| 30.199219 | 47 | 0.247986 | 0.144989 | 29 | 0 | 0 |
no
| 0.1 | 0.1 |
dnr after sadm
| 2 | 137 | 11.898438 | 75 | 24 | 38.89844 | null | null | 1.399902 | 4.699219 | 126 | null | null | 90 | 5,200 | null | 5 |
<2 mo. follow-up
| 5 |
1,477 | 69.56897 | 0 |
male
| 0 | 10 | 462 |
COPD
|
COPD/CHF/Cirrhosis
| 2 | 8 | null | 0 | 35,691 | 16,373.8594 | 12,696.5859 | 16 |
black
| 21.796875 | 30 | 0.820923 | 0.708984 | 1 | 1 | 0 |
no
| 0.9 | 0.7 |
no dnr
| 10 | 117 | 11.699219 | 175 | 16 | 36.09375 | 157.125 | null | null | 2.099609 | 138 | 7.269531 | 184 | 43 | 1,699 | 6 | 5 | null | 5 |
1,478 | 71.12396 | 1 |
female
| 1 | 12 | 12 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 44 | 227,604 | 49,044.9688 | 51,175.7188 | 45 |
black
| 42.296875 | 92 | 0.065994 | 0.022999 | 12 | 0 | 0 |
no
| 0.1 | 0.05 |
dnr after sadm
| 2 | 111 | 8 | 110 | 30 | 36.39844 | 197.5 | null | null | 0.799927 | 136 | 7.449219 | 265 | 14 | 1,150 | null | null |
<2 mo. follow-up
| 3.089844 |
1,479 | 65.52997 | 0 |
female
| 0 | 13 | 463 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 8 |
under $11k
| 0 | 32,728 | 18,566 | 14,167.7578 | 15.5 |
black
| 16.699219 | 11 | 0.890991 | 0.817993 | 1 | 0 | 0 |
no
| 0.75 | 0.7 |
no dnr
| 13 | 75 | 8.898438 | 78 | 22 | 36.79688 | null | null | null | 0.799927 | 138 | null | null | null | 3,100 | 1 | 0 | null | 0 |
1,480 | 60.65997 | 1 |
female
| 0 | 16 | 51 |
Coma
|
Coma
| 1 | null | null | 9 | 59,110 | 27,980.5625 | 30,758.3438 | 12 |
hispanic
| 20.199219 | 15 | 0.637939 | 0.577881 | 1 | 0 | 0 |
metastatic
| 0 | 0 |
dnr before sadm
| -1 | 103 | 6.699219 | 78 | 22 | 38.5 | null | null | 0.5 | 1 | 140 | null | 86 | 11 | 1,050 | null | null |
<2 mo. follow-up
| 2.899414 |
1,481 | 75.16199 | 0 |
male
| 0 | 12 | 461 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 20 |
>$50k
| 0 | 43,004 | 18,532.2344 | 19,595.6094 | 26.5 |
white
| 13.898438 | 42 | 0.892944 | 0.819946 | 1 | 0 | 0 |
no
| 0.95 | 0.9 |
no dnr
| 12 | 50 | null | 95 | 32 | 37.5 | 367.5 | 1.799805 | 10.199219 | 2.199707 | 142 | 7.439453 | 200 | 112 | 3,425 | 1 | 0 |
no(M2 and SIP pres)
| 0 |
1,482 | 60.72299 | 1 |
male
| 1 | 15 | 15 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | null | null | 44 | 165,860 | 56,255.9062 | 54,786.0312 | 38.666657 |
white
| 39.195313 | 73 | 0.219971 | 0.122986 | 4 | 0 | 0 |
no
| 0.75 | 0.7 |
dnr after sadm
| 11 | 143 | 0.049995 | 135 | 36 | 35.5 | 540 | 3 | null | 1.5 | 135 | 7.55957 | null | 29 | 2,480 | null | null |
<2 mo. follow-up
| 3.604492 |
1,483 | 54.67499 | 1 |
male
| 0 | 10 | 250 |
Colon Cancer
|
Cancer
| 1 | 16 |
>$50k
| 0 | 32,539 | 14,322.4609 | 17,685.9688 | 14.5 |
white
| 25.296875 | 5 | 0.701904 | 0.415955 | 1 | 0 | 0 |
metastatic
| 0.8 | 0.5 |
no dnr
| 10 | 73 | 5.199219 | 76 | 24 | 36.39844 | null | null | null | 1.099854 | 136 | null | null | 3 | 2,400 | null | null | null | 2.959473 |
1,484 | 56.00299 | 0 |
male
| 0 | 24 | 460 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 10 | null | 0 | 130,715 | 66,234.25 | 43,036.0625 | 18.666656 |
white
| 21 | 22 | 0.876953 | 0.794922 | 1 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 24 | 68 | 46.5 | 150 | 40 | 39.29688 | 130 | 3 | 16.097656 | 2.299805 | 150 | 7.539062 | 300 | 63 | 2,420 | 0 | 0 | null | 0 |
1,485 | 58.54599 | 0 |
female
| 0 | 6 | 460 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | null | null | 0 | 11,516 | 7,043.5547 | 5,208.17969 | 12 |
white
| 18.5 | 24 | 0.86499 | 0.776978 | 1 | 1 | 0 |
yes
| 1 | 0.7 |
no dnr
| 6 | 72 | 7.799805 | 135 | 10 | 36.69531 | 391.8125 | null | 0.399963 | 0.699951 | 136 | 7.519531 | 103 | 7 | 5,660 | null | null | null | 3.390137 |
1,486 | 78.27496 | 1 |
female
| 1 | 7 | 7 |
Coma
|
Coma
| 0 | null | null | 37 | 63,413 | 19,578.7656 | 22,750.2344 | 38 |
asian
| 35.695313 | 38 | 0.043999 | 0.021999 | 8 | 0 | 0 |
no
| 0.2 | 0.5 |
no dnr
| 7 | 52 | 12.898438 | 120 | 40 | 39.79688 | 148.875 | 3.399902 | null | 3.599609 | 143 | 7.459961 | null | 87 | 73 | null | null |
<2 mo. follow-up
| 2.394531 |
1,487 | 79.07495 | 1 |
female
| 0 | 8 | 183 |
CHF
|
COPD/CHF/Cirrhosis
| 4 | 12 |
under $11k
| 0 | 14,921 | 9,544.6016 | 7,000.54688 | 18.5 |
white
| 20 | 34 | 0.771973 | 0.636963 | 1 | 1 | 0 |
yes
| 0.6 | 0.4 |
dnr before sadm
| -1 | 69 | 9.699219 | 120 | 16 | 36.79688 | null | 1.799805 | null | 0.599976 | 140 | null | null | 16 | null | null | 3 |
no(M2 and SIP pres)
| 3 |
1,488 | 71.146 | 1 |
male
| 0 | 3 | 402 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 19 |
>$50k
| 0 | 8,208 | 4,140.8594 | 3,448.91992 | 15 |
white
| 20.5 | 35 | 0.836914 | 0.73291 | 1 | 1 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 3 | 52 | 22.296875 | 125 | 24 | 36.19531 | null | 3.099609 | null | 1.799805 | 138 | null | null | 47 | 1,925 | null | null |
no(M2 and SIP pres)
| 2.431152 |
1,489 | 47.20898 | 0 |
male
| 0 | 16 | 458 |
CHF
|
COPD/CHF/Cirrhosis
| 3 | 12 |
$25-$50k
| 0 | 120,554 | 50,712.9062 | 49,997.125 | 21 |
white
| 27.796875 | 24 | 0.827881 | 0.718994 | 1 | 0 | 0 |
no
| 0.95 | 0.92 |
no dnr
| 16 | 163 | 17 | 116 | 22 | 36 | 300 | null | null | 1.199951 | 139 | 7.379883 | 282 | 26 | 1,925 | null | 0 | null | 0 |
1,490 | 52.97198 | 1 |
male
| 0 | 5 | 74 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 9 |
$25-$50k
| 0 | 109,462 | 9,459.1641 | 15,796.4297 | 36 |
white
| 26.597656 | 27 | 0.761963 | 0.621948 | 18 | 0 | 0 |
no
| 0.7 | 0.55 |
no dnr
| 5 | 52 | 44.5 | 150 | 14 | 38.29688 | 225.4375 | 3 | 25.796875 | 4.899414 | 142 | 7.419922 | 94 | 76 | 28 | null | 3 |
SIP>=30
| 3 |
1,491 | 59.28299 | 1 |
female
| 1 | 31 | 31 |
MOSF w/Malig
|
ARF/MOSF
| 1 | 12 |
$11-$25k
| 41 | 263,478 | 96,814.8125 | 83,578.5 | 26.75 |
black
| 29.597656 | 47 | 0.309998 | 0.196991 | 4 | 0 | 0 |
yes
| 0.6 | 0.6 |
dnr after sadm
| 26 | 105 | 6.199219 | 105 | 24 | 36.79688 | null | null | null | 1.099854 | 139 | null | 92 | 14 | 4,950 | null | 5 |
<2 mo. follow-up
| 5 |
1,492 | 66.92096 | 1 |
female
| 1 | 3 | 3 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null |
under $11k
| 100 | 259,419 | 10,136.9922 | 9,748.00781 | 29 |
hispanic
| 81.6875 | 116 | 0 | 0 | 41 | 1 | 0 |
no
| 0.2 | 0.2 |
no dnr
| 3 | 103 | 20.199219 | 105 | 20 | 36.79688 | null | null | null | 0.699951 | 141 | null | 172 | 9 | 1,750 | null | 0 |
<2 mo. follow-up
| 0 |
1,493 | 44.89297 | 1 |
female
| 0 | 7 | 174 |
Colon Cancer
|
Cancer
| 1 | 12 |
>$50k
| 0 | null | 6,676.3672 | 7,199.01953 | 10 |
white
| 9.5 | 14 | 0.915894 | 0.803955 | 1 | 0 | 0 |
metastatic
| 0.9 | 0.3 |
no dnr
| 7 | 55 | 12.798828 | 75 | 12 | 38.29688 | null | 3.399902 | 0.899902 | 1.699951 | 138 | null | 128 | 30 | 1,920 | 0 | null | null | 0.494751 |
1,494 | 52.323 | 0 |
male
| 0 | 13 | 454 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 14 |
$11-$25k
| 0 | 108,450 | 65,760.8125 | 49,937.4688 | 34 |
white
| 26.097656 | 40 | 0.830933 | 0.723999 | 1 | 0 | 0 |
no
| 0.9 | 0.85 |
no dnr
| 13 | 55 | 11.298828 | 35 | 10 | 35 | 262.5 | 1.899902 | 20.5 | 1.699951 | 138 | 7.40918 | 229 | 55 | 2,211 | null | null |
no(M2 and SIP pres)
| 3.303711 |
1,495 | 41.60699 | 1 |
female
| 1 | 13 | 13 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0 | null | null | 41 | 590,617 | 62,744.5312 | 57,986.75 | 37.5 |
hispanic
| 43.695313 | 84 | 0.185974 | 0.096985 | 15 | 0 | 0 |
no
| 0.1 | 0.05 |
dnr after sadm
| 12 | 83 | 10.898438 | 76 | 16 | 36.59375 | null | 2.599609 | 1 | 0.899902 | 137 | null | 100 | 11 | 2,840 | null | null |
<2 mo. follow-up
| 2.734375 |
1,496 | 53.50299 | 0 |
male
| 0 | 17 | 453 |
CHF
|
COPD/CHF/Cirrhosis
| 2 | 14 |
>$50k
| 0 | 150,298 | 90,096 | 65,634.875 | 30.333328 |
white
| 21.5 | 31 | 0.876953 | 0.795898 | 1 | 0 | 0 |
no
| 0.8 | 0.7 |
no dnr
| 17 | 63 | 12.699219 | 125 | 26 | 39.09375 | null | 3.699707 | 1.299805 | 1.299805 | 138 | null | 154 | 14 | 2,670 | 0 | 0 | null | 0 |
1,497 | 73.24799 | 1 |
male
| 0 | 7 | 24 |
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2 | 18 | null | 9 | 12,039 | 6,354.4219 | 6,221.9375 | 8 |
white
| 25.699219 | 45 | 0.531982 | 0.332947 | 1 | 0 | 0 |
no
| 0.3 | 0.3 |
dnr after sadm
| 2 | 107 | 6.899414 | 75 | 20 | 36 | null | null | null | 1.899902 | 142 | null | 167 | 40 | 2,850 | null | null |
<2 mo. follow-up
| 2.677246 |
1,498 | 74.17395 | 1 |
female
| 1 | 23 | 23 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1 | null | null | 0 | 322,777 | 102,572.188 | 107,645.438 | 40 |
white
| 28.597656 | 54 | 0.621948 | 0.517944 | 7 | 1 | 0 |
no
| 0.9 | 0.9 |
dnr after sadm
| 22 | 42 | 23.398438 | 105 | 10 | 36.29688 | 316 | null | null | 2 | 135 | 7.25 | null | 40 | 2,650 | null | null |
<2 mo. follow-up
| 2.542969 |
1,499 | 57.49799 | 1 |
male
| 1 | 9 | 9 |
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3 | 17 |
>$50k
| 26 | 347,324 | null | null | 36 |
white
| 40.796875 | 58 | 0.22699 | 0.127991 | 21 | 0 | 0 |
no
| 0.2 | 0.05 |
dnr after sadm
| 6 | 70 | 6.199219 | 70 | 20 | 36.5 | null | null | null | 2.799805 | 139 | null | null | 59 | 1,175 | null | 0 |
<2 mo. follow-up
| 0 |
1,500 | 72.20294 | 1 |
male
| 0 | 9 | 146 |
Lung Cancer
|
Cancer
| 1 | 18 |
$11-$25k
| 0 | 38,812 | 18,041.3594 | 19,459.875 | 9.5 |
white
| 20.398438 | 23 | 0.61499 | 0.29895 | 1 | 0 | 0 |
metastatic
| 0.65 | 0.4 |
no dnr
| 9 | 72 | 6.399414 | 75 | 22 | 37 | null | null | null | 2.399902 | 131 | null | 153 | 77 | 600 | null | null |
no(M2 and SIP pres)
| 3.495117 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.